8-10 September 2026 Marseille
| 1-RFC2 | Distinct spontaneous growth trajectories during first three years of life in children with achondroplasia | Klaus Mohnike | |
| 1-RFC4 | Phenotypic Spectrum of NKX2-1-Related Disorders expands to craniofacial malformation, immunodeficiency and lipid myopathy. | Beatriz Villafuerte | |
| 2-RFC3 | Somapacitan in Children and Adolescents Born Small for Gestational Age: 2-Year REAL8 Results Including Switch From Daily GH | Beverly La Ferla | |
| 3-RFC3 | Somapacitan in Children and Adolescents with Idiopathic Short Stature: 2-Year REAL8 Results Including Switch from Daily GH | Beverly La Ferla | |
| 3-RFC1 | MULTIOMIC ANALYSIS OF PAEDIATRIC PARAGANGLIOMAS REVEALS THEIR DEVELOPMENTAL ORIGIN AND TUMOUR HETEROGENEITY | Michaela Kuhlen | |
| 5-RFC2 | Monitoring and optimizing bone health in spinal muscular atrophy: The Newcastle experience | Elisabeth Wray | |
| 5-RFC6 | Higher health care utilization and increased risk of incident ADHD and autism spectrum disorder in young men with a history of delayed puberty | Otto Orre | |
| 5-RFC9 | Baseline Growth and Metabolic Predictors of Growth Hormone Responsiveness to LUM-201 Versus Standard Stimulation in Children with Moderate GHD | Adam Stevens | |
| 1002-P | Predicting short Synacthen test outcome in children and adolescents using salivary 11-oxygenated androgens, cortisol and cortisone | Joseph Tonge | |
| 1004-P | Service Evaluation of a novel Waking Salivary Cortisone screening test for adrenal insufficiency in children. | Charlotte Elder | |
| 1006-P | Sustained ACTH and 17-Hydroxyprogesterone Reductions and Improved Clinical Outcomes With Up to 2 Years of Crinecerfont in Pediatric Patients with Classic Congenital Adrenal Hyperplasia | LeAnn Berens | |
| 1010-P | Salivary 11-oxygenated androgens during short Synacthen testing in children and adolescents: associations with age, BMI and exogenous steroid exposure | Joseph Tonge | |
| 1015-P | Deep histomics of pediatric adrenocortical tumors: vision-transformer whole-slide embeddings capture molecular and endocrine phenotype signals | Michaela Kuhlen | |
| 1025-P | A retrospective study of Adrenal Recovery in Children Tapering from Corticosteroids in three UK centres (ARCTiC Study) | Charlotte Elder | |
| 1037-P | Analytical Performance of an Automated LC-MS/MS Analyzer for Measurement of Steroids relevant to Congenital Adrenal Hyperplasia | Dusanka Kasapic | |
| 1038-P | A Phase 2/3 and Open-Label Extension Study of Atumelnant in Paediatric Patients with Classic Congenital Adrenal Hyperplasia: BALANCE-CAH | Stephanie Hand | |
| 1042-P | Immunoassay overestimates cortisol concentrations in poorly controlled congenital adrenal hyperplasia | Meera Shaunak | |
| 1044-P | A case of hyperaldosteronism in an 11 year old male | Anita Azam | |
| 1045-P | Clinical presentation and genotype-phenotype correlation in a large Italian cohort of children and adolescents with congenital adrenal hyperplasia due to 21-Hydroxylase Deficiency | Francesca Romana Rotondo | |
| 1046-P | A case of Triple A Syndrome due to a novel mutation in AAAS gene | Olga Slavcheva - Prodanova | |
| 1050-P | Early-Onset Médication-Related Osteonecrosis of the Jaw in Duchenne Muscular Dystrophy : First Cases in Adolescents on Antiresorptives. | Agathe Rio | |
| 1052-P | Evaluating Transition in Osteogenesis Imperfecta in the West of Scotland | Molly Orr | |
| 1081-P | Autosomal Dominant Hypocalcemia Type 1 and Type 2: Baseline Burden of Disease and Quality of Life in Pediatric Participants in the CLARIFY Disease Monitoring Study | Raja Padidela | |
| 1084-P | PROPEL Infant and Toddler: Study design and ongoing enrollment of a phase 2/2b study of infigratinib in children under 3 years old with achondroplasia | Melita Irving | |
| 1118-P | Beyond Autoimmunity: Expanding Phenotype of a Pathogenic CTLA4 Variant from Early-Onset Type 1 Diabetes Mellitus to Acquired Lipodystrophy and Severe Insulin Resistance | Yu Ding | |
| 1121-P | Cognitive Impairment in Type 2 Diabetes Mellitus via the PRLR/JAK2/STAT5 Signaling Pathway | Yan Sun | |
| 1129-P | Insulin Therapy´s Differential Effects on Cystic Fibrosis Over a 2-Year Period: Improvement in CFRD, and Stabilization of Nutritional and Pulmonary Outcomes in Early Glycemic Abnormalities | Dogus Vuralli | |
| 1137-P | Impact of Digital Health Interventions on Clinical Outcomes in Paediatric Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-analysis | Eirena Beh | |
| 1144-P | URINARY GROWTH DIFFERENTIATION FACTOR 15 (uGDF-15) AS AN EARLY BIOMARKER OF DIABETIC NEPHROPATHY IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES | Maira Arkoumani | |
| 1145-P | Voices from Families of Children with Type 1 Diabetes in Indonesia: A Health Needs Assessment | Ghaisani Fadiana | |
| 1147-P | HYPOGLYCEMIA: A NOVEL PHENOTYPE IN A PEDIATRIC PATIENT WITH LONG QT SYNDROME (LQTS) | &924;&913;&929;&921;&913; &922;&913;&929;&913;&925;&932;&918;&913; | |
| 1152-P | Assessing the effectiveness of hybrid closed-Loop systems in optimising diabetes care for children and young people with type 1 diabetes mellitus | Divyani Bhudia | |
| 1170-P | Genome-Wide Association Analysis and HLA Genotyping of 37 Children with Etiology-Unknown Autoantibody-Negative Type 1 Diabetes Mellitus | Chisato Narita | |
| 1185-P | Vitamin Status, Adiposity, and Cardiometabolic Risk in Children and Adolescents living in Switzerland: Results from menuCH-Kids 2023–2024 and the VITAKIDS project. | Maria-Christina Antoniou | |
| 1191-P | Miglitol Attenuates Diet-Induced Steatohepatitis with Suppression of the Hepatic 5-LOX/LTB4 Axis in Juvenile Mice | Chiharu Cho | |
| 1200-P | Implications for the future: PWS as an independent risk factor for LDL hypercholesterolemia | Constanze Lämmer | |
| 1208-P | Experience with Setmelanotide Use in Heterozygous Variants under Compassionate Use | César David Molina | |
| 1212-P | Relative Fat Mass (RFM) and Cardiometabolic Risk Factors in Youth From Normal-Weight (NW) to Obesity and Dysglycemia | Silva Arslanian | |
| 1223-P | Title: Evira® MedTech Device for Weight Management in Paediatric Complications of Excess Weight (CEW) Clinics: A Regional Evaluation in the UK | Jodi Wood | |
| 1248-P | Adrenal function screening practices in neonates in the UK: a multicentre retrospective cohort study | Daniel Chan | |
| 1249-P | Persistent Treatment Burden and Glycemic Instability in Congenital Hyperinsulinism: Insights from the HI Global Registry | Kristen Rohli | |
| 1251-P | Picroside II Regulates Cuproptosis to Alleviate Metabolic Dysfunction-Associated Steatotic Liver Disease | Yan Sun | |
| 1257-P | Genetic and Imaging Characteristics of Patients with Congenital Hyperinsulinism undergoing 18-F DOPA PET imaging in Canada | Magdalena Koziak | |
| 1274-P | GROWTH WITHOUT GROWTH HORMONE (GWGH). Unravelling its peripheral GH-IGF axis | Maria Guemes | |
| 1279-P | Are short children born small for gestational age with disproportional shorter arms, forearms or hands at risk for a poor growth response to growth hormone? | Christine Derycke | |
| 1282-P | One-Quarter of Children Fail to Reach Target Height Following Discontinuation of Growth Hormone Therapy After Normal First-Year Retesting: Predictors of Target Height Failure | Dogus Vuralli | |
| 1286-P | Has the clinical presentation of childhood growth hormone deficiency changed in the last two decades? The Belgian experience | Muriel Thomas | |
| 1287-P | Four-year efficacy and safety of somapacitan treatment in children with growth hormone deficiency (GHD): results from the REAL 4 trial | Beverly La Ferla | |
| 1288-P | Healthcare professional engagement with digital adherence monitoring and its association with adherence and catch-up growth in children receiving growth hormone therapy: Real-world data from Slovakia | Kunal Jain | |
| 1295-P | Baseline characteristics, treatment patterns and 12-month real-world effectiveness of somapacitan in patients with growth hormone deficiency (GHD): data from GloBE-Reg | Beverly La Ferla | |
| 1296-P | Growth response and IGF-I trajectories in Paediatric GHD patients treated with Long-Acting Versus Daily GH: Matched Real-World DATA from the INSIGHTS-GHT Registry | Joachim Woelfle | |
| 1308-P | Systematic targeted exome sequencing reveals pathogenic gene variants in familial short stature | anne sophie lambert | |
| 1311-P | HighLiGHts Phase 3 Trial Design: Lonapegsomatropin in Children With Short Stature or Growth Failure Due to Turner Syndrome, SHOX Deficiency, Small for Gestational Age, or Idiopathic Short Stature | Tilman Rohrer | |
| 1324-P | Prader-Willi Syndrome - Single centre experience | Irene Lo | |
| 1325-P | THE QEPS-GROWTH MODEL – A VALUABLE RESEARCH TOOL FOR COMPREHENSIVE ANALYSIS OF HUMAN GROWTH IN HEALTH AND DISEASE | Anton Holmgren | |
| 1329-P | International Consensus on the Diagnosis and Clinical Management of Idiopathic Short Stature: A Modified Delphi Study | Ryan Thompson | |
| 1339-P | Early rhIGF-1 treatment and adult height outcomes in Severe Primary IGF-I Deficiency: subgroup analysis from the Global Increlex® Registry | Magdalena Pérez | |
| 1345-P | Towards personalised notifications for growth hormone adherence in the Growzen® Buddy app | Kunal Jain | |
| 1356-P | Comparative Analysis of Google NotebookLM and Human Experts for Pediatric Bone Age Assessment | Kanjanaporn Sontipijitr | |
| 1360-P | The Growzen® Buddy smartphone app to improve catch-up growth in patients receiving recombinant human growth hormone therapy: A retrospective observational study in Argentina | Kunal Jain | |
| 1365-P | The estradiol upper limit level for benign premature thelarche is lower when determined by GC-MS/MS compared to extraction-RIA | Carina Ankarberg Lindgren | |
| 1388-P | Hashimoto´s Thyroiditis (Steroid Responsive Encephalopathy with Autoimmune Thyroiditis) : A rare life threatening presentation in an adolescent girl | Anusha Reddy | |
| 1393-P | Analytical Performance of an Automated LC-MS/MS Analyzer for Measurement of Estradiol and Testosterone | Dusanka Kasapic | |
| 1403-P | Serum levels of estradiol during the pubertal growth spurt – a semi longitudinal study of healthy girls | Jenni Gårdstedt Berghog | |
| 1424-P | Copeptin as an early biomarker of AVP-deficiency in paediatric pituitary surgery: a pilot study | Annabelle Piquet | |
| 1430-P | Adult Height Outcomes in Premature Adrenarche: Gender-Specific Predictors of Inability to Achieve Target Height | Dogus Vuralli | |
| 1437-P | Co-Designing a Patient Passport for Children with Hypopituitarism: A Participatory Approach to Improving Communication and Care | Annabelle Piquet | |
| 1438-P | Rare subtypes of craniopharyngioma- Giant craniopharyngioma & malignant transformation – a case series | Bryan Finn | |
| 1441-P | Metabolic outcomes associated with the use of Metformin in children with congenital and acquired hypopituitarism: a real-world cohort study | Daniel Chan | |
| 1443-P | Adrenarche and Puberty Induction in Turner Syndrome: Insights from a tertiary Belgian Paediatric Center | Emese Boros | |
| 1445-P | Evidence for extra-hypothalamic GnRHa actions via NOS1 on cognition and clinical implications for cryptorchidism. | Faruk Hadziselimovic | |
| 1450-P | Retrospective Study of the Paediatric Transgender Cohort of the Strasbourg University Hospital | François BREZIN | |
| 1462-P | Global variation, shared standards: Improving DSD genomic testing through External Quality Assessment | Melody Tabiner | |
| 1483-P | Does postponing of genital surgery in girls with congenital adrenal hyperplasia have an psychosocial impact on the families? | Luise Landreh | |
| 1496-P | Listening to the Patient Voice: Understanding and Assessing the Impact of Hypoparathyroidism on the Daily Lives of Adolescents | Allyson Marshall-Hudson | |
| 1499-P | Evaluation of the Clinical Course of Cases Followed up with Thyroid Nodules in Childhood and Adolescence: A Single Center Experience | Sevim Onguner | |
| 1505-P | Disrupted thyroid hormone signaling due to a novel THRA variant: functional characterization in a child with developmental delay | Agathe Rio | |
| 1508-P | Effects of Tiratricol Treatment Withdrawal in Monocarboxylate Transporter 8 (MCT8) Deficiency: The ReTRIACt Trial | Henna Oittinen Corbinelli | |
| 1519-P | From Congenital Goiter to Molecular Diagnosis: A Novel Thyroglobulin Splice-Site Mutation | Meghan Hickey | |
| 1534-P | Understanding and Assessing the Adolescent Patient Perspective of Symptoms in Hypoparathyroidism | Allyson Marshall-Hudson | |
| 2075-LBP | Longer-term efficacy and safety results of infigratinib in children with achondroplasia | Marie-Eve Robinson | |
| 2079-LBP | Prenatal Treatment with Dabogratinib Increases Both Long Bones and Size of the Foramen Magnum and Delays Premature Fusion of Synchondroses in a Mouse Model Mimicking Achondroplasia | Jacqueline Starrett | |
| 2081-LBP | Chronic Kidney Disease and Kidney Failure in Childhood-Onset Type 2 Diabetes: a population at high risk | Elizabeth Sellers | |
| 2085-LBP | Evaluating the effects of liraglutide on glycemic, metabolic, and enteroendocrine function in individuals with Maturity-Onset Diabetes of the Young | Lily Deng | |
| 2101-LBP | Multiple regions of loss of heterozygosity identified by paired tumor–germline whole-genome sequencing in a patient with ROHHAD syndrome | Akari Utsunomiya | |
| 2107-LBP | Voice frequencies in male and female infants during and after mini puberty | Maria Liapi | |
8-10 September 2026 Marseille

Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||
|
|